查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856946

全球診斷檢測套組市場：預測至 2032 年－按產品、技術、應用、最終用戶和地區分類的分析

Diagnostic Test Kits Market Forecasts to 2032 - Global Analysis By Product (Immunoassay Kits, Molecular Diagnostic Kits, Clinical Chemistry Kits and Other Products), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2025 年，全球診斷檢測套組市場規模將達到 3,103 億美元，到 2032 年將達到 5,458 億美元，預測期內複合年成長率為 8.4%。

診斷檢測套組是用於快速、準確地檢測、監測和診斷疾病及健康狀況的醫療工具。這些試劑盒包含試劑、設備和耗材，可在實驗室、照護現場或家庭中使用。它們有助於從血液、尿液、唾液和拭子等樣本中識別感染疾病、慢性病、遺傳性疾病和代謝性疾病。常見的類型包括快速抗原檢測、PCR 試劑盒和免疫檢測。診斷試劑盒在早期發現、治療方案製定和公共衛生監測中發揮著至關重要的作用。其便攜性、易用性和快速出結果的特點使其成為全球臨床診斷、緊急醫療救護和疫情應對中不可或缺的工具。

感染疾病和慢性病盛行率不斷上升

感染疾病和慢性病的日益增多是診斷檢測套組市場的主要驅動力。糖尿病、癌症、心血管疾病以及新出現的病毒感染疾病等疾病，都推動了快速、準確診斷解決方案的需求。早期發現對於有效治療和疾病管理至關重要，因此促使醫療機構採用先進的檢測套組。人口老化、生活方式的改變以及旨在擴大診斷覆蓋範圍和預防性醫療保健的全球健康舉措，也進一步推動了這一趨勢。

嚴格的監管核准

嚴格的監管核准限制了市場發展。製造商必須經歷複雜而漫長的認證過程才能達到安全、有效和品質標準。美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等監管機構要求進行大量的臨床檢驗、文件編制和合規性審查，這可能會延遲產品上市並增加研發成本。這些挑戰對中小企業和新興市場尤其沉重，可能限制創新並減緩醫療保健系統對新型診斷技術的應用。

技術進步

技術進步為市場帶來了巨大的成長機會。分子診斷、人工智慧平台和攜帶式檢測設備等創新技術正在提升檢測的準確性、速度和便利性。這些發展為個人化醫療、遠距離診斷和即時健康監測提供了支持。與數位健康生態系統的整合實現了無縫數據共用，並有助於改善臨床決策。隨著醫療系統將效率和以患者為中心的護理放在首位，對智慧、擴充性且方便用戶使用的診斷解決方案的需求預計將顯著成長。

先進設備的高成本

先進診斷檢測套組的高成本對市場擴張構成顯著威脅。微陣列、PCR系統和多重檢測等先進技術需要大量投資，這使得資源匱乏地區的人們難以取得這些技術。此外，設備、試劑和專業人員的營運成本也進一步加重了醫療預算的負擔。這種經濟障礙可能會阻礙這些技術的廣泛應用，尤其是在發展中地區，這限制了服務不足人口獲得尖端診斷方法的機會。

新冠疫情的影響：

新冠疫情對診斷檢測套組市場產生了重大影響。對快速抗原檢測和PCR檢測的需求激增，推動了全球範圍內的技術創新和生產規模擴大。疫情加速了監管核准、官民合作關係以及對診斷基礎設施的投資。同時，疫情也凸顯了分散式檢查和就地檢驗的重要性。疫情過後，市場繼續受益於人們對診斷的認知提高、準備工作加強以及診斷技術融入常規醫療保健的趨勢。此次疫情也改變了產業的優先事項，未來檢測套組的研發將更加重視速度、準確性和可及性。

預計在預測期內，微陣列細分市場將成為最大的細分市場。

預計在預測期內，微陣列技術將佔據最大的市場佔有率，因為微陣列能夠對遺傳物質進行高通量分析，使其在疾病譜分析和個人化醫療中發揮著極其重要的作用。微陣列能夠同時檢測多個標靶，從而提高診斷效率和準確性。微陣列廣泛應用於科學研究和臨床實驗室，支持腫瘤學、感染疾病和藥物基因組學等領域的應用。隨著對全面、精準診斷的需求不斷成長，微陣列技術在創新和應用方面將繼續保持領先地位。

預計腫瘤領域在預測期內將達到最高的複合年成長率。

預計在預測期內，腫瘤領域將達到最高成長率。癌症發病率的上升，以及對早期檢測和標靶治療的需求，正在推動對先進診斷解決方案的需求。腫瘤標記、基因突變和液態切片的檢測套組在臨床應用中日益普及。分子診斷和個人化醫療的技術進步進一步促進了成長。隨著癌症治療的不斷發展，腫瘤領域預計將迎來快速擴張和創新。

比最大的地區

由於快速的都市化、不斷擴大的醫療保健投資以及日益加重的疾病負擔，預計亞太地區將在預測期內佔據最大的市場佔有率。中國、印度和日本等國家正在擴大診斷基礎設施並採用先進技術。政府為促進預防性醫療保健和提高公眾健康意識而採取的措施也進一步推動了市場需求。亞太地區擁有龐大的患者群體，且醫療保健服務可近性不斷提高，預計將在全球診斷市場中佔據領先地位。

複合年成長率最高的地區：

預計北美在預測期內將實現最高的複合年成長率。這主要得益於該地區強大的醫療基礎設施、健全的法規結構以及創新技術的高度普及。對個人化醫療、慢性病管理和家庭診斷的日益重視將推動市場擴張。策略合作、研究經費投入以及人工智慧和數位平台的快速整合將進一步增強北美的醫療能力。北美正積極推動醫療現代化，並已成為診斷創新領域的領先中心。

免費客製化服務

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 原始研究資料
    • 二手研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 市場機遇
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 公司間的競爭

5. 全球診斷檢測套組市場（依產品分類）

  • 免疫檢測盒
    • ELISA試劑盒
    • 化學冷光免疫檢測(CLIA) 試劑盒
    • 橫向流動化驗（LFA）試劑盒
  • 分子診斷試劑盒
    • PCR試劑盒
    • 次世代定序盒
    • 等溫擴增試劑盒
  • 臨床化學試劑盒
    • 酵素試劑盒
    • 比色試劑盒
  • 微生物試劑盒
    • 培養基礎試劑盒
    • 快速鑑定試劑盒
  • 其他產品
    • 血液學試劑盒
    • 照護現場（PoC）試劑盒

6. 全球診斷檢測套組市場（依技術分類）

  • 聚合酵素鏈鎖反應（PCR）
  • 微陣列
  • 免疫檢測
  • 次世代定序
  • 橫向流動化驗
  • 其他技術

7. 全球診斷檢測套組市場（按應用分類）

  • 感染疾病
    • 病毒感染
    • 寄生蟲感染疾病
    • 細菌感染疾病
  • 瘤
  • 遺傳性疾病
  • 心血管疾病
  • 糖尿病
  • 其他用途

8. 全球診斷檢測套組市場（依最終用戶分類）

  • 醫院和診所
  • 研究和學術機構
  • 診斷實驗室
  • PoC 測試中心
  • 居家醫療
  • 其他最終用戶

9. 全球診斷檢測套組市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Siemens Healthineers
  • bioMerieux
  • GE Healthcare
  • Ortho Clinical Diagnostics
  • Roche
  • Qiagen
  • Danaher
  • Hologic
  • Quest Diagnostics
  • Sysmex Corporation
  • Abbott Laboratories
  • PerkinElmer
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories
Product Code: SMRC31810

According to Stratistics MRC, the Global Diagnostic Test Kits Market is accounted for $310.3 billion in 2025 and is expected to reach $545.8 billion by 2032 growing at a CAGR of 8.4% during the forecast period. Diagnostic test kits are medical tools designed to detect, monitor, and diagnose diseases or health conditions quickly and accurately. These kits include reagents, devices, and consumables used in laboratory, point-of-care, or home settings. They help identify infections, chronic illnesses, genetic disorders, and metabolic conditions through samples like blood, urine, saliva, or swabs. Common types include rapid antigen tests, PCR kits, and immunoassays. Diagnostic kits play a vital role in early detection, treatment planning, and public health surveillance. Their portability, ease of use, and fast results make them essential in clinical diagnostics, emergency care, and pandemic response efforts worldwide.

Market Dynamics:

Driver:

Rising prevalence of infectious and chronic diseases

The increasing prevalence of infectious and chronic diseases is a major driver of the Diagnostic Test Kits Market. Conditions such as diabetes, cancer, cardiovascular disorders, and emerging viral infections are fueling demand for rapid and accurate diagnostic solutions. Early detection is critical for effective treatment and disease management, prompting healthcare providers to adopt advanced test kits. This trend is further supported by aging populations, lifestyle changes, and global health initiatives aimed at improving diagnostic coverage and preventive care.

Restraint:

Stringent regulatory approvals

Stringent regulatory approvals pose a significant restraint to the Market. Manufacturers must navigate complex and time-consuming certification processes to meet safety, efficacy, and quality standards. Regulatory bodies such as the FDA and EMA require extensive clinical validation, documentation, and compliance, which can delay product launches and increase development costs. These challenges are particularly burdensome for smaller companies and emerging markets, potentially limiting innovation and slowing the adoption of new diagnostic technologies across healthcare systems.

Opportunity:

Advancements in technology

Technological advancements offer substantial opportunities for growth in the market. Innovations in molecular diagnostics, AI-powered platforms, and portable testing devices are enhancing accuracy, speed, and accessibility. These developments support personalized medicine, remote diagnostics, and real-time health monitoring. Integration with digital health ecosystems enables seamless data sharing and improved clinical decision-making. As healthcare systems prioritize efficiency and patient-centric care, the demand for smart, scalable, and user-friendly diagnostic solutions is expected to rise significantly.

Threat:

High cost of advanced kits

The high cost of advanced diagnostic test kits presents a notable threat to market expansion. Sophisticated technologies such as microarrays, PCR systems, and multiplex assays require substantial investment, making them less accessible in low-resource settings. Additionally, operational costs related to equipment, reagents, and skilled personnel further strain healthcare budgets. This financial barrier may hinder widespread adoption, particularly in developing regions, and limit the reach of cutting-edge diagnostics to underserved populations.

Covid-19 Impact:

The COVID-19 pandemic had a transformative impact on the Diagnostic Test Kits Market. Demand surged for rapid antigen and PCR tests, driving innovation and scaling production globally. The crisis accelerated regulatory approvals, public-private partnerships, and investment in diagnostic infrastructure. It also highlighted the importance of decentralized and point-of-care testing. Post-pandemic, the market continues to benefit from heightened awareness, preparedness, and integration of diagnostics into routine healthcare. The experience has reshaped industry priorities, emphasizing speed, accuracy, and accessibility in future test kit development.

The microarray segment is expected to be the largest during the forecast period

The microarray segment is expected to account for the largest market share during the forecast period as microarrays enable high-throughput analysis of genetic material, making them invaluable in disease profiling and personalized medicine. Their ability to simultaneously detect multiple targets enhances diagnostic efficiency and accuracy. Widely used in research and clinical laboratories, microarrays support applications in oncology, infectious diseases, and pharmacogenomics. As demand for comprehensive and precise diagnostics grows, the microarray segment continues to lead in innovation and adoption.

The oncology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the oncology segment is predicted to witness the highest growth rate, rising cancer incidence, coupled with the need for early detection and targeted therapies, is driving demand for advanced diagnostic solutions. Test kits for tumor markers, genetic mutations, and liquid biopsies are gaining traction in clinical settings. Technological advancements in molecular diagnostics and personalized medicine further support growth. As cancer care evolves, the oncology segment is poised for rapid expansion and innovation.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid urbanization, growing healthcare investments, and increasing disease burden. Countries like China, India, and Japan are expanding diagnostic infrastructure and adopting advanced technologies. Government initiatives promoting preventive care and public health awareness further boost demand. With a large patient population and rising access to healthcare services, Asia Pacific remains a dominant force in global diagnostics.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to region's robust healthcare infrastructure, strong regulatory framework, and high adoption of innovative technologies. Increasing focus on personalized medicine, chronic disease management, and home-based diagnostics supports expansion. Strategic collaborations, research funding, and rapid integration of AI and digital platforms further enhance capabilities. North America's proactive approach to healthcare modernization positions it as a leading hub for diagnostic innovation.

Key players in the market

Some of the key players in Diagnostic Test Kits Market include Siemens Healthineers, bioMerieux, GE Healthcare, Ortho Clinical Diagnostics, Roche, Qiagen, Danaher, Hologic, Quest Diagnostics, Sysmex Corporation, Abbott Laboratories, PerkinElmer, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Bio-Rad Laboratories.

Key Developments:

In June 2025, Abbott and MSD Pharmaceuticals announced a strategic partnership to distribute MSD's oral anti-diabetic medicines in India. This collaboration aims to leverage Abbott's extensive distribution network to expand access to these treatments, addressing the significant diabetes burden in India, where an estimated 101 million people are affected by the condition.

In March 2025, Cadrenal Therapeutics and Abbott have entered into a collaboration to advance tecarfarin, a novel oral anticoagulant, for patients with implanted left ventricular assist devices (LVADs). This partnership aims to enhance anticoagulation therapy by improving hemocompatibility and reducing complications associated with current treatments.

Products Covered:

  • Immunoassay Kits
  • Molecular Diagnostic Kits
  • Clinical Chemistry Kits
  • Microbiology Kits
  • Other Products

Technologies Covered:

  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Immunoassay
  • Next-Generation Sequencing
  • Lateral Flow Assay
  • Other Technologies

Applications Covered:

  • Infectious Disease
  • Oncology
  • Genetic Disorders
  • Cardiovascular Disease
  • Diabetes
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Research & Academic Institutes
  • Diagnostic Laboratories
  • Point-of-Care Testing Centers
  • Home Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Diagnostic Test Kits Market, By Product

  • 5.1 Introduction
  • 5.2 Immunoassay Kits
    • 5.2.1 ELISA Kits
    • 5.2.2 Chemiluminescence Immunoassay (CLIA) Kits
    • 5.2.3 Lateral Flow Assay (LFA) Kits
  • 5.3 Molecular Diagnostic Kits
    • 5.3.1 PCR Kits
    • 5.3.2 Next-Generation Sequencing Kits
    • 5.3.3 Isothermal Amplification Kits
  • 5.4 Clinical Chemistry Kits
    • 5.4.1 Enzymatic Kits
    • 5.4.2 Colorimetric Kits
  • 5.5 Microbiology Kits
    • 5.5.1 Culture-Based Kits
    • 5.5.2 Rapid Identification Kits
  • 5.6 Other Products
    • 5.6.1 Hematology Kits
    • 5.6.2 Point-of-Care (POC) Kits

6 Global Diagnostic Test Kits Market, By Technology

  • 6.1 Introduction
  • 6.2 Polymerase Chain Reaction (PCR)
  • 6.3 Microarray
  • 6.4 Immunoassay
  • 6.5 Next-Generation Sequencing
  • 6.6 Lateral Flow Assay
  • 6.7 Other Technologies

7 Global Diagnostic Test Kits Market, By Application

  • 7.1 Introduction
  • 7.2 Infectious Disease
    • 7.2.1 Viral Infections
    • 7.2.2 Parasitic Infections
    • 7.2.3 Bacterial Infections
  • 7.3 Oncology
  • 7.4 Genetic Disorders
  • 7.5 Cardiovascular Disease
  • 7.6 Diabetes
  • 7.7 Other Applications

8 Global Diagnostic Test Kits Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Research & Academic Institutes
  • 8.4 Diagnostic Laboratories
  • 8.5 Point-of-Care Testing Centers
  • 8.6 Home Care
  • 8.7 Other End Users

9 Global Diagnostic Test Kits Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Siemens Healthineers
  • 11.2 bioMerieux
  • 11.3 GE Healthcare
  • 11.4 Ortho Clinical Diagnostics
  • 11.5 Roche
  • 11.6 Qiagen
  • 11.7 Danaher
  • 11.8 Hologic
  • 11.9 Quest Diagnostics
  • 11.10 Sysmex Corporation
  • 11.11 Abbott Laboratories
  • 11.12 PerkinElmer
  • 11.13 Thermo Fisher Scientific
  • 11.14 Becton, Dickinson and Company (BD)
  • 11.15 Bio-Rad Laboratories

List of Tables

  • Table 1 Global Diagnostic Test Kits Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Diagnostic Test Kits Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Diagnostic Test Kits Market Outlook, By Immunoassay Kits (2024-2032) ($MN)
  • Table 4 Global Diagnostic Test Kits Market Outlook, By ELISA Kits (2024-2032) ($MN)
  • Table 5 Global Diagnostic Test Kits Market Outlook, By Chemiluminescence Immunoassay (CLIA) Kits (2024-2032) ($MN)
  • Table 6 Global Diagnostic Test Kits Market Outlook, By Lateral Flow Assay (LFA) Kits (2024-2032) ($MN)
  • Table 7 Global Diagnostic Test Kits Market Outlook, By Molecular Diagnostic Kits (2024-2032) ($MN)
  • Table 8 Global Diagnostic Test Kits Market Outlook, By PCR Kits (2024-2032) ($MN)
  • Table 9 Global Diagnostic Test Kits Market Outlook, By Next-Generation Sequencing Kits (2024-2032) ($MN)
  • Table 10 Global Diagnostic Test Kits Market Outlook, By Isothermal Amplification Kits (2024-2032) ($MN)
  • Table 11 Global Diagnostic Test Kits Market Outlook, By Clinical Chemistry Kits (2024-2032) ($MN)
  • Table 12 Global Diagnostic Test Kits Market Outlook, By Enzymatic Kits (2024-2032) ($MN)
  • Table 13 Global Diagnostic Test Kits Market Outlook, By Colorimetric Kits (2024-2032) ($MN)
  • Table 14 Global Diagnostic Test Kits Market Outlook, By Microbiology Kits (2024-2032) ($MN)
  • Table 15 Global Diagnostic Test Kits Market Outlook, By Culture-Based Kits (2024-2032) ($MN)
  • Table 16 Global Diagnostic Test Kits Market Outlook, By Rapid Identification Kits (2024-2032) ($MN)
  • Table 17 Global Diagnostic Test Kits Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 18 Global Diagnostic Test Kits Market Outlook, By Hematology Kits (2024-2032) ($MN)
  • Table 19 Global Diagnostic Test Kits Market Outlook, By Point-of-Care (POC) Kits (2024-2032) ($MN)
  • Table 20 Global Diagnostic Test Kits Market Outlook, By Technology (2024-2032) ($MN)
  • Table 21 Global Diagnostic Test Kits Market Outlook, By Polymerase Chain Reaction (PCR) (2024-2032) ($MN)
  • Table 22 Global Diagnostic Test Kits Market Outlook, By Microarray (2024-2032) ($MN)
  • Table 23 Global Diagnostic Test Kits Market Outlook, By Immunoassay (2024-2032) ($MN)
  • Table 24 Global Diagnostic Test Kits Market Outlook, By Next-Generation Sequencing (2024-2032) ($MN)
  • Table 25 Global Diagnostic Test Kits Market Outlook, By Lateral Flow Assay (2024-2032) ($MN)
  • Table 26 Global Diagnostic Test Kits Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 27 Global Diagnostic Test Kits Market Outlook, By Application (2024-2032) ($MN)
  • Table 28 Global Diagnostic Test Kits Market Outlook, By Infectious Disease (2024-2032) ($MN)
  • Table 29 Global Diagnostic Test Kits Market Outlook, By Viral Infections (2024-2032) ($MN)
  • Table 30 Global Diagnostic Test Kits Market Outlook, By Parasitic Infections (2024-2032) ($MN)
  • Table 31 Global Diagnostic Test Kits Market Outlook, By Bacterial Infections (2024-2032) ($MN)
  • Table 32 Global Diagnostic Test Kits Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 33 Global Diagnostic Test Kits Market Outlook, By Genetic Disorders (2024-2032) ($MN)
  • Table 34 Global Diagnostic Test Kits Market Outlook, By Cardiovascular Disease (2024-2032) ($MN)
  • Table 35 Global Diagnostic Test Kits Market Outlook, By Diabetes (2024-2032) ($MN)
  • Table 36 Global Diagnostic Test Kits Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 37 Global Diagnostic Test Kits Market Outlook, By End User (2024-2032) ($MN)
  • Table 38 Global Diagnostic Test Kits Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 39 Global Diagnostic Test Kits Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
  • Table 40 Global Diagnostic Test Kits Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 41 Global Diagnostic Test Kits Market Outlook, By Point-of-Care Testing Centers (2024-2032) ($MN)
  • Table 42 Global Diagnostic Test Kits Market Outlook, By Home Care (2024-2032) ($MN)
  • Table 43 Global Diagnostic Test Kits Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.